Myriad – Finding Shadowbox

Discover how one of the nation’s largest genetic testing and precision medicine companies began solving their interoperability challenges.

Myriad’s Urology division provides state-of-the-art genetic testing supporting risk factors related to men’s health.  This rapidly growing division at Myriad struggled to automate the test ordering process for their customers as the internal IT department already managed a hefty pipeline of scheduled projects with limited bandwidth to code more traditional or API integrations. That’s when Sam Sgambati, Myriad’s National Director for Sales and Strategic Accounts found Shadowbox.

They asked Shadowbox to enable their clinician customers to implement an electronic ordering and resulting process for the Prolaris and MyRisk Hereditary Cancer tests without requiring the use of Myriad’s internal IT resources.  That’s exactly what happened.  Shadowbox digitized Myriad’s order forms and embedded them in a white-labeled “Myriad Test Ordering Application” installed on the clinician’s desktop computer.  With a single click, a patient’s critical diagnostic, demographic, and insurance information is transferred to the digital order form. The clinician completes the order and submits it electronically to Myriad where the order awaits for the specimen to arrive at the lab. This out-of-the-box solution can be installed in a new clinician’s office in a matter of minutes with zero use of Myriad’s internal IT resources.

As a result of the successful easy-ordering solution, Myriad commissioned Shadowbox to add a feature that automatically notifies the referring physician (usually the pathologist) that a Myriad test has been ordered and once completed, automatically provides them with an electronic copy of the results.  Following this implementation, Myriad continues to identify and consider other opportunities to implement Shadowbox across the enterprise.

Shadowbox tech is an elegant solution that enables us to begin transitioning clinicians from paper to electronic ordering. They did so without taxing our internal resources.

Sam Sgambati, National Director, Sales & Strategic Accounts, Urology Myriad Genetics